News

Stop TB Partnership’s Coordinating Board Meets in DC

Today was the opening of the 2-day Stop TB Partnership’s Coordinating Board (CB) meeting in Washington, D.C. which included welcoming remarks by Dr. Rajiv Shah (Administrator, USAID), Ms. Lois Quam (Executive Director, GHI), and Dr. Howard Koh (Assistant Secretary, U.S. Depart. of HHS). Having the meeting in the capital of the U.S. has been a great advocacy opportunity to help reinforce the commitment of the U.S. Government and partners to allocating resources to tuberculosis. During the days preceding the CB meeting, several high level missions were organized with heads of U.S. agencies and the esteemed Ministers of Health from South Africa, Lesotho, and Swaziland.

The board meets biannually to provide leadership and direction, to monitor the implementation of agreed policies, to plan activities of the Partnership, and to ensure coordination among Stop TB Partnership components. The Working Group on New Drugs is represented on the board.

Links to related news:

Southern African “A-Team” takes on TB

India: As the middle class rises, so does tuberculosis

SA nursing still plagued by many challenges

Motsoaledi forms partnership with American agencies

More funding for TB research and development needed, new report says

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...